Status:
NOT_YET_RECRUITING
Information Sources in Pulmonary Hypertension
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Pulmonary Arterial Hypertension (PAH)
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary hypertension is a serious disease that affects patients' health, daily life, and emotional well-being. Many patients and their caregivers actively look for information to better understand t...
Detailed Description
Pulmonary hypertension (PH) is a chronic and progressive disease often diagnosed late, which forces patients and caregivers to actively seek information to understand and manage the condition. The com...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Confirmed diagnosis of pulmonary hypertension (any clinical group) or informal caregiver of a patient with pulmonary hypertension
- Ability to read and understand the questionnaire
- Signed informed consent (ICF/TCLE)
Exclusion
- Inability to understand or complete the questionnaire
- Refusal to participate or not signing the informed consent
Key Trial Info
Start Date :
November 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07207525
Start Date
November 1 2025
End Date
March 1 2027
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05403-900